Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Pharmacology|May 15, 2023
Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signallingVinochani Pillay, Lipi Shukla, Prad Herle, et al.
Cancer Discovery|December 4, 2023
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid TumorsCatherine Dietrich, Alec Trub, Antonio Ahn, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 11, 2021
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer OrganoidsNicholas Choo, Susanne Ramm, Jennii Luu, et al.
EMBO Molecular Medicine|December 14, 2020
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell deathSophia Ceder, Sofi E Eriksson, Emarndeena H Cheteh, et al.
NAR Genomics and Bioinformatics|August 26, 2024
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinomaOlivia Craig, Samuel Lee, Courtney Pilcher, et al.
Cancer Cell|March 16, 2016
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 InhibitorsShom Goel, Qi Wang, April C Watt, et al.
JCI Insight|December 21, 2018
Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicityElijah J Weber, Kevin A Lidberg, Lu Wang, et al.
Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Nature|August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunityShom Goel, Molly J DeCristo, April C Watt, et al.
British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Pageof 2